1-((4R,5S)-4,5-DIHYDROXY-N2-(4-(5-(4-(PENTYLOXY)PHENYL)-3-ISOXAZOLYL)BENZOYL)-L-ORNITHINE)-4-((4S)-4-HYDROXY-4-(4-HYDROXY-3-(SULFOOXY)PHENYL)-L-THREONINE)PNEUMOCANDIN A0
UNII XV78DZW9MA
Substance Identification & Data
This profile provides standardized clinical and technical data for 1-((4r,5s)-4,5-dihydroxy-n2-(4-(5-(4-(pentyloxy)phenyl)-3-isoxazolyl)benzoyl)-l-ornithine)-4-((4s)-4-hydroxy-4-(4-hydroxy-3-(sulfooxy)phenyl)-l-threonine)pneumocandin A0, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XV78DZW9MA.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1392514-01-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C56H71N9O23S PIEUQSKUWLMALL-NJVYOUANSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1-((4r,5s)-4,5-dihydroxy-n2-(4-(5-(4-(pentyloxy)phenyl)-3-isoxazolyl)benzoyl)-l-ornithine)-4-((4s)-4-hydroxy-4-(4-hydroxy-3-(sulfooxy)phenyl)-l-threonine)pneumocandin A0. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.